A carregar...

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients

BACKGROUND AND AIMS: Chronic hepatitis C (HCV) is a liver disease affecting over 3 million Americans. Liver biopsy is the gold standard for assessing liver fibrosis and is used as a benchmark for initiating treatment, though it is expensive and carries risks of complications. FibroTest is a non-inva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Shan, Schwarzinger, Michaël, Carrat, Fabrice, Goldhaber-Fiebert, Jeremy D.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3229483/
https://ncbi.nlm.nih.gov/pubmed/22164204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0026783
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!